Autolus Therapeutics Plc (AUTL)
1.165
-0.02
(-2.10%)
USD |
NASDAQ |
Nov 13, 16:00
1.165
0.00 (0.00%)
After-Hours: 19:59
Autolus Therapeutics Net Income (Quarterly) : -55.06M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -55.06M |
| June 30, 2026 | -39.18M |
| March 31, 2026 | -71.48M |
| December 31, 2025 | -90.20M |
| September 30, 2025 | -78.62M |
| June 30, 2025 | -48.51M |
| March 31, 2025 | -70.16M |
| December 31, 2024 | -27.35M |
| September 30, 2024 | -82.09M |
| June 30, 2024 | -58.27M |
| March 31, 2024 | -52.69M |
| December 31, 2023 | -77.17M |
| September 30, 2023 | -45.58M |
| June 30, 2023 | -45.71M |
| March 31, 2023 | -40.17M |
| December 31, 2022 | -27.15M |
| Date | Value |
|---|---|
| September 30, 2022 | -42.77M |
| June 30, 2022 | -42.06M |
| March 31, 2022 | -37.06M |
| December 31, 2021 | -41.67M |
| September 30, 2021 | -33.99M |
| June 30, 2021 | -33.17M |
| March 31, 2021 | -33.27M |
| December 31, 2020 | -42.86M |
| September 30, 2020 | -37.32M |
| June 30, 2020 | -32.04M |
| March 31, 2020 | -29.87M |
| December 31, 2019 | -40.94M |
| September 30, 2019 | -27.25M |
| June 30, 2019 | -28.48M |
| March 31, 2019 | -27.18M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | -10.47M |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| NuCana Plc | -4.134M |
| Mereo BioPharma Group Plc | -5.860M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 41.22M |
| Total Expenses (Quarterly) | 96.28M |
| EPS Diluted (Quarterly) | -0.2068 |
| Enterprise Value | 508.24M |
| Gross Profit Margin (Quarterly) | 56.53% |
| Profit Margin (Quarterly) | -133.6% |
| Earnings Yield | -82.53% |
| Normalized Earnings Yield | -82.45 |